Newsroom

News

Regarding the current reporting on the origin of the coronavirus SARS-CoV-2, Prof. Fabian Leendertz, Director of the Helmholtz Institute for One Health (HIOH), makes the following statement: “Based on the data published to date, it can be assumed that the transmission to humans took place via intermediate hosts (e.g. animal farms), as the contacts and risks are much higher there. This data has been published in various WHO reports and relevant peer-reviewed scientific publications. If there is now other and new data that supports an origin in the laboratory, then that is a different picture. We now have to wait until this data has been examined and reviewed by experts.”

13.03.2025

HIOH

Interview

Dr Natalia Torow researches the immune system of newborns, seeking to understand how it responds to pathogens and vaccinations to better prevent early-life infections. Since 2024, she has led the junior research group "Early Life Immunity" at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, introducing a new research focus to the institution. In this interview, she discusses the neonatal immune system’s "silent mode," her goal of optimizing oral vaccines, and how she balances life as a researcher with family responsibilities.

06.03.2025

HZI Campus

News

In May 2022, alarming headlines emerged: A mysterious and deadly disease was spreading in Central Africa. Was this the beginning of a new pandemic? Today, we know that it was Mpox (formerly known as monkeypox), a viral disease that has once again been declared a public health emergency. In this episode of the HZI podcast Infact, Dr Julia Port, head of the research group “Laboratory of Transmission Immunology” at the Helmholtz Centre for Infection Research (HZI), discusses virus transmission and the role of the immune system. Her research bridges immunology, viral ecology, and global health.

27.02.2025

HZI Campus

Fabian Leendertz with a group of students standing with their backs to the camera

News

Today, the Citizen Science project CiFly will enter its second year. This year, 9th and 10th grade students from the Alexander-von-Humboldt-Gymnasium will again have the opportunity to get to know the Helmholtz Institute for One Health (HIOH), but also the chance to explore the biobank of the University Medical Center and the Greifswald Zoo from the perspective of a researcher.

27.02.2025

HIOH

[Translate to English:] 3D-kontrastierte Oberflächenstruktur von LasB (beige) mit einem Inhibitor der 3. Generation (dunkelblau), der Zink (grau) bindet.

News

Infectious keratitis blinds 1.5 million people worldwide every year. This severe eye disease is often caused by the hospital germ Pseudomonas aeruginosa, which the World Health Organization considers one of the most dangerous bacteria of its kind. Now, scientists at Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have found a way to combat this resilient pathogen. Their study has been published in Advanced Science. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

24.02.2025

HIPS

HZI Campus

Cryo-electron microscopy image: The anti-CRISPR protein AcrVIB1 (magenta) attaches to the nuclease Cas13b (light gray)

News

The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to antiviral therapies and diagnostics. However, to safely harness their powers, scientists are searching for mechanisms that can regulate or inhibit the systems’ activity. Enter the anti-CRISPR protein AcrVIB1, a promising inhibitor whose exact function has remained a mystery—until now. A research team from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, in collaboration with the Helmholtz Centre for Infection Research (HZI) in Braunschweig, has uncovered the precise way AcrVIB1 works that expands the known means by which Acrs can shut down CRISPR. The results were published today in the journal Molecular Cell.

17.02.2025

HZI Campus

HIRI

Back to the first page
...
11
12
13
14
...
148

HZI in the media

new antiviral medicines, says virologist Christian Sieben of the Helmholtz Centre for Infection Research in Germany.

Earlier in 2025, for

10.11.2025

The Press

Hochschule Hannover, die Universitätsmedizin Göttingen, das Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die KI-

07.11.2025

Heise online

... , Leiter der Forschungsgruppe Mikrobielle Wirkstoffe am Helmholtz-Zentrum für Infektionsforschung, zu bedenken. Das erste ...

07.11.2025

Leipziger Volkszeitung (LVZ)

Quelle: Pressemitteilung

HZI-Helmholtz Zentrum für Infektionsforschung ...

04.11.2025

LaborPraxis

Forschende des Helmholtz-Zentrums für Infektionsforschung und der Universität Würzburg entwickeln derzeit einen Kaugummi, der Grippeviren

04.11.2025

Arbeitsmedizin-Sozialmedizin-Umweltmedizin

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025

Augsburger Allgemeine

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025

bild der wissenschaft

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025

MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025

innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025

Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025

Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025

PROCESS

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.